SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Denis Chem Lab - Quaterly Results

28 May 2024 Evaluate
The total revenue for the quarter ended March 2024 remained nearly unchanged at Rs. 398.55 millions.The Total revenue for the quarter ended March 2024 of  Rs. 27.30  millions  grew by 252.26% from Rs. 7.75 millions.Operating profit for the quarter ended March 2024 rose to 56.74 millions as compared to 50.81 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 398.55 397.27 0.32 1678.22 1608.49 4.34 1678.22 1608.49 4.34
Other Income 5.95 3.37 76.56 13.88 5.92 134.46 13.88 5.92 134.46
PBIDT 56.74 50.81 11.67 226.21 193.73 16.77 226.21 193.73 16.77
Interest 2.35 2.62 -10.31 5.43 6.41 -15.29 5.43 6.41 -15.29
PBDT 54.39 48.19 12.87 220.78 187.32 17.86 220.78 187.32 17.86
Depreciation 17.49 37.23 -53.02 69.46 78.15 -11.12 69.46 78.15 -11.12
PBT 36.90 10.96 236.68 151.32 109.17 38.61 151.32 109.17 38.61
TAX 9.60 3.21 199.07 39.76 30.56 30.10 39.76 30.56 30.10
Deferred Tax -2.58 -6.63 -61.09 -8.90 -5.97 49.08 -8.90 -5.97 49.08
PAT 27.30 7.75 252.26 111.56 78.61 41.92 111.56 78.61 41.92
Equity 138.77 138.77 0.00 138.77 138.77 0.00 138.77 138.77 0.00
PBIDTM(%) 14.24 12.79 11.31 13.48 12.04 11.91 13.48 12.04 11.91

Denis Chem Lab Share Price

78.42 -1.85 (-2.30%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×